secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001562762-25-000164
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed projects $18-25M Medicare Cap hit; lowers FY2025 guidance
----------------------------------------------------------------

- VITAS expects $18M-$25M Medicare Cap revenue limit for Florida consolidated program (excl. Tallahassee) in 2025 Cap Year.
- Lower-than-expected Medicare admissions in Apr-May 2025 and rate differential (2.9% cap increase vs 5.2% reimbursement) caused the cap.
- Roto-Rooter experienced unexpected residential demand weakness in Q2 2025; commercial improvement insufficient to offset.
- VITAS received Florida CON for Pinellas County on June 20, aiding growth and Cap mitigation for 2026.
- Full Q2 2025 results and revised FY2025 guidance due July 29; conference call July 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000164/0001562762-25-000164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000164/che-20250627x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer